Latest Insider Transactions at In Med Pharmaceuticals Inc. (INM)
This section provides a real-time view of insider transactions for In Med Pharmaceuticals Inc. (INM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of InMed Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of InMed Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2024
|
Andrew Hull Director |
BUY
Open market or private purchase
|
Direct |
37,500
+49.5%
|
$0
$0.39 P/Share
|
|
Feb 20
2024
|
Eric A Adams President & CEO |
BUY
Open market or private purchase
|
Direct |
41,600
+48.62%
|
$0
$0.36 P/Share
|
|
Apr 14
2022
|
Eric A Adams President & CEO |
BUY
Open market or private purchase
|
Direct |
14,160
+19.35%
|
$0
$0.89 P/Share
|
|
Apr 13
2022
|
Eric A Adams President & CEO |
BUY
Open market or private purchase
|
Direct |
8,560
+16.03%
|
$0
$0.85 P/Share
|
|
Jan 24
2022
|
Bruce Colwill CFO |
BUY
Open market or private purchase
|
Direct |
5,000
+30.28%
|
$5,000
$1.09 P/Share
|
|
Jan 06
2022
|
Shane Aaron Johnson Sr VP & General Manager |
BUY
Open market or private purchase
|
Direct |
8,500
+2.71%
|
$8,500
$1.26 P/Share
|
|
Dec 30
2021
|
Shane Aaron Johnson Sr VP & General Manager |
BUY
Open market or private purchase
|
Direct |
8,093
+2.66%
|
$8,093
$1.33 P/Share
|
|
Nov 15
2021
|
Shane Aaron Johnson Sr VP & General Manager |
BUY
Open market or private purchase
|
Direct |
5,000
+1.71%
|
$5,000
$1.37 P/Share
|
|
Sep 29
2021
|
Eric A Adams President & CEO |
BUY
Open market or private purchase
|
Direct |
8,800
+19.52%
|
$8,800
$1.73 P/Share
|
|
Sep 28
2021
|
Bruce Colwill CFO |
BUY
Open market or private purchase
|
Direct |
5,000
+43.42%
|
$5,000
$1.77 P/Share
|
|
Sep 28
2021
|
Eric A Adams President & CEO |
BUY
Open market or private purchase
|
Direct |
11,400
+29.32%
|
$11,400
$1.75 P/Share
|